Helping people to tackle a number of ailments is the main aim of this collaboration

To help people get rid of various fatal diseases, StemRx Bioscience Solutions Pvt. Ltd., in association with Amity Institute of Biotechnology, Navi Mumbai, organized a one day International seminar on how technologies like Tissue Nanotransfection, bone marrow transplant, organ transplant, and umbilical cord blood transplantation can change the future course of various diseases like cancer.

Along with Dr. Pradeep Mahajan, many other dignitaries like Dr. Chandan K. Sen, Director, Indian Center for Regenerative Medicine and Engineering , Indiana University, USA; Dr. M. Gopinath, Principal Scientist, CFTRI, Mysore; Dr. Satyandra Katewa, Head, Department of Paediatric Hematology-Oncology and Bone Marrow Transplant, Jaipur; Dr. Sunali Khanna, Nair Hospital, Mumbai; Dr. Deepa Bhartiya, Senior Scientific Officer, NIRRH, Mumbai, and Dr. Neetin Desai, Director, Amity Institute Of Biotechnology were part of the workshop.

Today, the Indian healthcare sector is growing at a brisk pace. With the help of advanced medical technologies, it is now possible to treat diseases with efficacy. The technological advancements are changing the very face of medicine. Thus, to help people tackle a number of ailments StemRx Biosciences Solutions Pvt. Ltd tied up with Amity Institute of Biotechnology, Navi Mumbai.

Dr. Pradeep Mahajan, Regenerative Medicine Researcher, Mumbai explained, The seminar highlighted how technologies like Tissue Nanotransfection, bone marrow, transplant, organ transplant, and umbilical cord blood transplantation can help treat various diseases like cancer, and infertility. I conducted a session on how new age medicine, regenerative medicine, and cell-based therapy can be a good option for people to tackle cancer, autoimmune diseases, urinary problems, neurological disorders, spinal cord injuries, and weak immune systems. Cell-based therapy can solve the majority of diseases without having conflicts.The newest technology Tissue Nanotransfection is going to create a revolution in cell-based therapy. I am honored, proud, and will look forward to many more associations with Amity in the near future.

More than 300 participants including the students, gynecologists, and government authorities were present for the seminar.

See more here:
StemRx Biosciences joins hands with Amity Institute of Biotechnology - BSI bureau